108 related articles for article (PubMed ID: 16272484)
1. Relationship between MIC and minimum sterol 14{alpha}-demethylation-inhibitory concentration as a factor in evaluating activities of azoles against various fungal species.
Shimokawa O; Niimi M; Kikuchi K; Saito M; Kajiwara H; Yoshida S
J Clin Microbiol; 2005 Nov; 43(11):5547-9. PubMed ID: 16272484
[TBL] [Abstract][Full Text] [Related]
2. Estimation of minimum sterol 14alpha-demethylation-inhibitory concentration of azoles in Candida yeasts using acetate-mediated growth inhibition: potential utility in susceptibility testing.
Shimokawa O; Nakayama H
J Clin Microbiol; 2000 Aug; 38(8):2893-6. PubMed ID: 10921946
[TBL] [Abstract][Full Text] [Related]
3. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
4. Posaconazole is a potent inhibitor of sterol 14alpha-demethylation in yeasts and molds.
Munayyer HK; Mann PA; Chau AS; Yarosh-Tomaine T; Greene JR; Hare RS; Heimark L; Palermo RE; Loebenberg D; McNicholas PM
Antimicrob Agents Chemother; 2004 Oct; 48(10):3690-6. PubMed ID: 15388421
[TBL] [Abstract][Full Text] [Related]
5. Acetate-mediated growth inhibition in sterol 14alpha-demethylation-deficient cells of Candida albicans.
Shimokawa O; Nakayama H
Antimicrob Agents Chemother; 1999 Jan; 43(1):100-5. PubMed ID: 9869573
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan.
Yamazaki T; Inagaki Y; Fujii T; Ohwada J; Tsukazaki M; Umeda I; Kobayashi K; Shimma N; Page MG; Arisawa M
Int J Antimicrob Agents; 2010 Oct; 36(4):324-31. PubMed ID: 20674282
[TBL] [Abstract][Full Text] [Related]
7. Antifungal activities and cytotoxicity studies of six new azasordarins.
Herreros E; Almela MJ; Lozano S; Gomez de las Heras F; Gargallo-Viola D
Antimicrob Agents Chemother; 2001 Nov; 45(11):3132-9. PubMed ID: 11600368
[TBL] [Abstract][Full Text] [Related]
8. [Susceptibility to miconazole and itraconazole of Candida strains isolated from hospitalized and outpatient clinic patients].
Kurnatowska AK; Kwaśniewska J
Wiad Parazytol; 2009; 55(4):415-23. PubMed ID: 20209818
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
[TBL] [Abstract][Full Text] [Related]
10. Voriconazole activity against clinical yeast isolates: a multicentre Italian study.
Morace G; Polonelli L;
Int J Antimicrob Agents; 2005 Sep; 26(3):247-53. PubMed ID: 16051469
[TBL] [Abstract][Full Text] [Related]
11. [Antifungal susceptibility of yeasts by Etest. Comparison of 3 media].
Tapia C; León E; Palavecino E
Rev Med Chil; 2003 Mar; 131(3):299-302. PubMed ID: 12790079
[TBL] [Abstract][Full Text] [Related]
12. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
Fujita S
Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
[TBL] [Abstract][Full Text] [Related]
13. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
[TBL] [Abstract][Full Text] [Related]
14. Initial results from a longitudinal international surveillance programme for anidulafungin (2003).
Messer SA; Kirby JT; Sader HS; Fritsche TR; Jones RN
J Antimicrob Chemother; 2004 Dec; 54(6):1051-6. PubMed ID: 15564286
[TBL] [Abstract][Full Text] [Related]
15. DNA microarray based on arrayed-primer extension technique for identification of pathogenic fungi responsible for invasive and superficial mycoses.
Campa D; Tavanti A; Gemignani F; Mogavero CS; Bellini I; Bottari F; Barale R; Landi S; Senesi S
J Clin Microbiol; 2008 Mar; 46(3):909-15. PubMed ID: 18160452
[TBL] [Abstract][Full Text] [Related]
16. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
[TBL] [Abstract][Full Text] [Related]
17. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.
Singh J; Rimek D; Kappe R
Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441
[TBL] [Abstract][Full Text] [Related]
19. Optically active antifungal azoles: synthesis and antifungal activity of (2R,3S)-2-(2,4-difluorophenyl)-3-(5-[2-[4-aryl-piperazin-1-yl]-ethyl]-tetrazol-2-yl/1-yl)-1-[1,2,4]-triazol-1-yl-butan-2-ol.
Upadhayaya RS; Sinha N; Jain S; Kishore N; Chandra R; Arora SK
Bioorg Med Chem; 2004 May; 12(9):2225-38. PubMed ID: 15080922
[TBL] [Abstract][Full Text] [Related]
20. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
Chiu YS; Chang SC; Hsueh PR; Wang JL; Sun HY; Chen YC
J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
